Answers From the Lab Archives - Page 16 of 25 - Insights
Skip to Content MayoACCESS MayoLINK...
MCL Combined Immunodeficiency Severe Combined Immunodeficiency BCellAntibody Deficiency Patient Information Complete print Reset Form Combined Immunodeficiency Severe Combined Immunodeficiency Cell Antibody Deficiency Patient Information...
MCL Early Onset Inflammatory Bowel Disease Patient Information MC1235310
MCL Early Onset Inflammatory Bowel Disease Patient Information Complete print Reset Form Early Onset Inflammatory Bowel Disease Patient Information Instructions Accurate interpretation reporting genetic results
MCL Hereditary Renal Genetic Testing Patient Information Form MC1235292
MCL Hereditary Renal Genetic Testing Patient Information Form Complete print Hereditary Renal Genetic Testing Patient Information Reset Form Instructions accurate interpretation reporting genetic
MCL Genetics Whole Genome Sequencing Flyer MC2775658
MCL Genetics Genome Sequencing Flyer GENOME SEQUENCING COMPREHENSIVE GENETIC TESTING ADVANCE DIAGNOSIS Clinic Laboratories genome sequencing WGS test utilizes generation
Optic Neuritis in the Era of Biomarkers - Insights
Antibodies to aquaporin-4 and myelin oligodendrocyte glycoprotein (MOG) are recently described biomarkers seen in a subset of atypical optic neuritis which have revolutionized our understanding of the condition. In this “Hot Topic,” my...
Patient-focused pragmatism: The Mayo Clinic innovation model - Insights
In a world of ever-faster technical change, Mayo Clinic Laboratories is uniquely positioned to innovate. Collaboration with clinicians pinpoints unmet patient needs and facilitates the development of diagnostic testing that provides...
Improving diagnosis of rare congenital disorders - Insights
Experts at Mayo Clinic have developed a unique method of testing that combines new technology with novel bioinformatics to promptly detect a group of uncommon genetic conditions that are often difficult to identify.
Testing for a surprising antigen enables insight into a chronic kidney illness - Insights
Mayo Clinic renal pathologist Dr. Sanjeev Sethi identified NELL-1 as a biomarker for membranous nephropathy (MN) in 2019. Two years later, Dr. Sethi helped implement the first ever IHC test to detect NELL-1 antigen, which appears in about...
Learn more about how Mayo Clinic Laboratories’ test offerings and services can help hospital laboratories enhance patient care and laboratory performance.